Today
-2.48%
5 Days
-8.41%
1 Month
-12.03%
6 Months
-24.10%
Year to Date
-29.90%
1 Year
-38.35%
• Alibaba faced downward momentum amid cautious market sentiment toward Chinese technology equities. • Massive capital expenditures for AI infrastructure compressed near-term margins and free cash flow. • Geopolitical export controls and supply caps limit high-performance semiconductor access for cloud scaling.
• Alibaba rose on institutional optimism for its artificial intelligence cloud operations. • Heavy capital expenditures for infrastructure caused scrutiny over near-term profit pressures. • The stock has an average analyst price target of $183.75.
• Alibaba shares rose due to technical rebounds and positive market sentiment. • Executive share vesting signaled operational stability and strong leadership alignment. • The company reported $144.14 billion in latest annual revenue.
• Alibaba shares fell despite AI chip unveilings due to profit-taking and spending fears. • Analysts raised capital expenditure forecasts, intensifying concerns over free cash flow contraction. • Legal filings, geopolitical headwinds, and export curbs continue to cap valuation multiples.
• Alibaba unveiled the Zhenwu V900 AI processor at the Apsara Conference. • Leadership plans to train foundation models scaling up to ten trillion parameters. • Annual revenue reached $144.14B with net profit totaling $14.91B.
• Alibaba faced volatility from share dilution, capital expenditures, and regulatory scrutiny. • Persistent margin compression occurred due to heavy cloud and AI spending. • Technical indicators show neutral conditions, while the Williams %R suggests oversold.
Alibaba (BABA) FY2027 Q1 Earnings Call: Cloud Revenue Grows 45%


| Shareholders | Proportion |
|---|---|
| PRIMECAP Management Company | 0.78% |
| JP Morgan Asset Management | 0.62% |
| Dodge & Cox | 0.42% |
| Fidelity Management & Research Company LLC | 0.32% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 6.20% |
| Investment Advisor/Hedge Fund | 2.75% |
| Research Firm | 1.17% |
| Hedge Fund | 0.69% |
Related Instruments